

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.95742449 |
| 2 | vocalization behavior (GO:0071625) | 5.49347018 |
| 3 | synaptic vesicle maturation (GO:0016188) | 5.47836229 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.47077416 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.33720790 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.29741994 |
| 7 | glutamate secretion (GO:0014047) | 5.14034034 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.07247674 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.89250203 |
| 10 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.84090808 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.70499863 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.69035522 |
| 13 | neuronal action potential propagation (GO:0019227) | 4.68342175 |
| 14 | * cellular sodium ion homeostasis (GO:0006883) | 4.51696323 |
| 15 | exploration behavior (GO:0035640) | 4.49227590 |
| 16 | neurotransmitter secretion (GO:0007269) | 4.43871614 |
| 17 | protein localization to synapse (GO:0035418) | 4.43143561 |
| 18 | glutamate receptor signaling pathway (GO:0007215) | 4.38144374 |
| 19 | neuron cell-cell adhesion (GO:0007158) | 4.35836668 |
| 20 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.35178950 |
| 21 | regulation of synaptic vesicle transport (GO:1902803) | 4.27625095 |
| 22 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.27081304 |
| 23 | cerebellar granule cell differentiation (GO:0021707) | 4.25458994 |
| 24 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.21193420 |
| 25 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.14561486 |
| 26 | synaptic transmission, glutamatergic (GO:0035249) | 4.12478247 |
| 27 | neuron-neuron synaptic transmission (GO:0007270) | 4.01118200 |
| 28 | layer formation in cerebral cortex (GO:0021819) | 3.99214977 |
| 29 | gamma-aminobutyric acid transport (GO:0015812) | 3.96489850 |
| 30 | proline transport (GO:0015824) | 3.95518916 |
| 31 | long-term memory (GO:0007616) | 3.80632537 |
| 32 | * cell communication involved in cardiac conduction (GO:0086065) | 3.80438556 |
| 33 | regulation of synapse structural plasticity (GO:0051823) | 3.78198621 |
| 34 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.74079920 |
| 35 | neurotransmitter transport (GO:0006836) | 3.72036590 |
| 36 | neuron recognition (GO:0008038) | 3.71276229 |
| 37 | positive regulation of synapse maturation (GO:0090129) | 3.69394779 |
| 38 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.65157672 |
| 39 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.51482636 |
| 40 | activation of protein kinase A activity (GO:0034199) | 3.51358327 |
| 41 | dendritic spine morphogenesis (GO:0060997) | 3.50788733 |
| 42 | regulation of synaptic plasticity (GO:0048167) | 3.50711701 |
| 43 | positive regulation of membrane potential (GO:0045838) | 3.49447348 |
| 44 | regulation of postsynaptic membrane potential (GO:0060078) | 3.48986432 |
| 45 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.44736126 |
| 46 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.44666866 |
| 47 | response to parathyroid hormone (GO:0071107) | 3.44544448 |
| 48 | long-term synaptic potentiation (GO:0060291) | 3.41232340 |
| 49 | regulation of neurotransmitter levels (GO:0001505) | 3.40602509 |
| 50 | transmission of nerve impulse (GO:0019226) | 3.39304228 |
| 51 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.39128761 |
| 52 | * relaxation of cardiac muscle (GO:0055119) | 3.37093186 |
| 53 | synaptic vesicle endocytosis (GO:0048488) | 3.35635285 |
| 54 | axonal fasciculation (GO:0007413) | 3.33958270 |
| 55 | regulation of vesicle fusion (GO:0031338) | 3.29422675 |
| 56 | response to histamine (GO:0034776) | 3.29419109 |
| 57 | * potassium ion homeostasis (GO:0055075) | 3.29418012 |
| 58 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.29348704 |
| 59 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.27916752 |
| 60 | regulation of cell communication by electrical coupling (GO:0010649) | 3.27866195 |
| 61 | neuromuscular process controlling posture (GO:0050884) | 3.27544123 |
| 62 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.23406537 |
| 63 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.22657245 |
| 64 | * cellular potassium ion homeostasis (GO:0030007) | 3.22615542 |
| 65 | serotonin metabolic process (GO:0042428) | 3.18411332 |
| 66 | * regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.18062744 |
| 67 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.16510355 |
| 68 | behavioral fear response (GO:0001662) | 3.16468253 |
| 69 | behavioral defense response (GO:0002209) | 3.16468253 |
| 70 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.16062956 |
| 71 | vesicle transport along microtubule (GO:0047496) | 3.15710839 |
| 72 | neuromuscular process controlling balance (GO:0050885) | 3.15557044 |
| 73 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.13510641 |
| 74 | regulation of neurotransmitter secretion (GO:0046928) | 3.13223294 |
| 75 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.11578933 |
| 76 | innervation (GO:0060384) | 3.09871432 |
| 77 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.08702795 |
| 78 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.08582149 |
| 79 | mating behavior (GO:0007617) | 3.04177987 |
| 80 | membrane depolarization during action potential (GO:0086010) | 3.03317324 |
| 81 | L-amino acid import (GO:0043092) | 3.03304676 |
| 82 | fear response (GO:0042596) | 3.02588653 |
| 83 | membrane depolarization (GO:0051899) | 3.02272099 |
| 84 | * cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.00841654 |
| 85 | synaptic transmission (GO:0007268) | 2.97162873 |
| 86 | membrane hyperpolarization (GO:0060081) | 2.96962332 |
| 87 | detection of calcium ion (GO:0005513) | 2.96507362 |
| 88 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.94813828 |
| 89 | synapse assembly (GO:0007416) | 2.93556340 |
| 90 | glycine transport (GO:0015816) | 2.93395157 |
| 91 | learning (GO:0007612) | 2.92772692 |
| 92 | postsynaptic membrane organization (GO:0001941) | 2.92379869 |
| 93 | cardiac conduction (GO:0061337) | 2.92269493 |
| 94 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.91936631 |
| 95 | relaxation of smooth muscle (GO:0044557) | 2.90820495 |
| 96 | startle response (GO:0001964) | 2.90740986 |
| 97 | regulation of dendritic spine development (GO:0060998) | 2.90346888 |
| 98 | long term synaptic depression (GO:0060292) | 2.90340795 |
| 99 | central nervous system myelination (GO:0022010) | 2.90181881 |
| 100 | axon ensheathment in central nervous system (GO:0032291) | 2.90181881 |
| 101 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.89888576 |
| 102 | intraspecies interaction between organisms (GO:0051703) | 2.88756072 |
| 103 | social behavior (GO:0035176) | 2.88756072 |
| 104 | regulation of neurotransmitter transport (GO:0051588) | 2.88721668 |
| 105 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.88217964 |
| 106 | regulation of synaptic transmission (GO:0050804) | 2.87529326 |
| 107 | dendrite morphogenesis (GO:0048813) | 2.87039800 |
| 108 | * sodium ion homeostasis (GO:0055078) | 2.86423831 |
| 109 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.86204419 |
| 110 | dendritic spine organization (GO:0097061) | 2.85611469 |
| 111 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.84639325 |
| 112 | * potassium ion import (GO:0010107) | 2.84320002 |
| 113 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.82886307 |
| 114 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.82511765 |
| 115 | primary amino compound metabolic process (GO:1901160) | 2.82378384 |
| 116 | positive regulation of neurotransmitter transport (GO:0051590) | 2.81826930 |
| 117 | organelle transport along microtubule (GO:0072384) | 2.81707129 |
| 118 | positive regulation of dendritic spine development (GO:0060999) | 2.81567818 |
| 119 | * sodium ion export (GO:0071436) | 2.80783824 |
| 120 | regulation of ARF protein signal transduction (GO:0032012) | 2.80666184 |
| 121 | positive regulation of synaptic transmission (GO:0050806) | 2.78985855 |
| 122 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.78943158 |
| 123 | * cell communication by electrical coupling (GO:0010644) | 2.78897400 |
| 124 | behavioral response to cocaine (GO:0048148) | 2.77998701 |
| 125 | chemosensory behavior (GO:0007635) | 2.77890572 |
| 126 | neuromuscular process (GO:0050905) | 2.77832010 |
| 127 | regulation of synapse maturation (GO:0090128) | 2.76532116 |
| 128 | amino acid import (GO:0043090) | 2.75929719 |
| 129 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.67893017 |
| 130 | * regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.62391540 |
| 131 | short-term memory (GO:0007614) | 2.61099018 |
| 132 | cerebellar Purkinje cell layer development (GO:0021680) | 2.60461279 |
| 133 | neurotransmitter uptake (GO:0001504) | 2.58277266 |
| 134 | neuronal ion channel clustering (GO:0045161) | 2.54460972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.08307803 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.40510899 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.15163075 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.12705077 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.02607947 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.70965977 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.70965977 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.67126451 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.65031615 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.62016057 |
| 11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.57257479 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.52208537 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.50087460 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48465730 |
| 15 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.47790428 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.45850349 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.29730356 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.22548557 |
| 19 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.20715014 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.19647635 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.15973941 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.15415563 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.07648389 |
| 24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.88011052 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.85252203 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.78829066 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.74577385 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.73027786 |
| 29 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.72462361 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.71751305 |
| 31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.70810991 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.70569217 |
| 33 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.67276515 |
| 34 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.66783393 |
| 35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.60128078 |
| 36 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.57460263 |
| 37 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.53086314 |
| 38 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.45014168 |
| 39 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.42775479 |
| 40 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36975599 |
| 41 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.35860313 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35682189 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.35528101 |
| 44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33552180 |
| 45 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.30681277 |
| 46 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.29836241 |
| 47 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29320938 |
| 48 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.29121893 |
| 49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28719028 |
| 50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.28513336 |
| 51 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.28502624 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27878157 |
| 53 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26499391 |
| 54 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.26417484 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25037811 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23435129 |
| 57 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.21491460 |
| 58 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20244275 |
| 59 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18900250 |
| 60 | AR_19668381_ChIP-Seq_PC3_Human | 1.18755950 |
| 61 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.18326476 |
| 62 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.17797100 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17231061 |
| 64 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.16204788 |
| 65 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.14907169 |
| 66 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14015132 |
| 67 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.13427408 |
| 68 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.13397977 |
| 69 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13356612 |
| 70 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13043136 |
| 71 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12759754 |
| 72 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11878637 |
| 73 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11509309 |
| 74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10469488 |
| 75 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09186691 |
| 76 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08991097 |
| 77 | VDR_22108803_ChIP-Seq_LS180_Human | 1.07330452 |
| 78 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.07149909 |
| 79 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.06242415 |
| 80 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.05513558 |
| 81 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04977505 |
| 82 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04898515 |
| 83 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03519494 |
| 84 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02858865 |
| 85 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01608432 |
| 86 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.01568715 |
| 87 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.01123779 |
| 88 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.01112025 |
| 89 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00635217 |
| 90 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00304525 |
| 91 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.00018979 |
| 92 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99919852 |
| 93 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99498873 |
| 94 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99088591 |
| 95 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98725050 |
| 96 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98273722 |
| 97 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97735460 |
| 98 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.97539330 |
| 99 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96745999 |
| 100 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95432158 |
| 101 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95265628 |
| 102 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95147543 |
| 103 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.95134562 |
| 104 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94880617 |
| 105 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.94762091 |
| 106 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94623576 |
| 107 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.94315521 |
| 108 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.92260864 |
| 109 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92031559 |
| 110 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91273171 |
| 111 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.91105237 |
| 112 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90782869 |
| 113 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.90039856 |
| 114 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89671869 |
| 115 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.88893789 |
| 116 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.87837365 |
| 117 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86321211 |
| 118 | JUN_21703547_ChIP-Seq_K562_Human | 0.85110634 |
| 119 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.83691966 |
| 120 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.83125514 |
| 121 | * FUS_26573619_Chip-Seq_HEK293_Human | 0.81004485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.45307220 |
| 2 | MP0003880_abnormal_central_pattern | 5.00288186 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.17479122 |
| 4 | MP0004270_analgesia | 3.64064785 |
| 5 | MP0009745_abnormal_behavioral_response | 3.46162058 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.29988031 |
| 7 | MP0002064_seizures | 3.17532844 |
| 8 | MP0009046_muscle_twitch | 3.10614909 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.98870999 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.78501588 |
| 11 | MP0002272_abnormal_nervous_system | 2.61280389 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.55735218 |
| 13 | MP0001501_abnormal_sleep_pattern | 2.51053904 |
| 14 | MP0002822_catalepsy | 2.49476625 |
| 15 | MP0002736_abnormal_nociception_after | 2.42425452 |
| 16 | MP0001486_abnormal_startle_reflex | 2.41029108 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.39822067 |
| 18 | MP0001440_abnormal_grooming_behavior | 2.38076165 |
| 19 | MP0005423_abnormal_somatic_nervous | 2.31414222 |
| 20 | MP0003329_amyloid_beta_deposits | 2.26006834 |
| 21 | MP0000678_abnormal_parathyroid_gland | 2.25913669 |
| 22 | MP0003195_calcinosis | 2.10710110 |
| 23 | MP0002733_abnormal_thermal_nociception | 2.07892481 |
| 24 | MP0002067_abnormal_sensory_capabilities | 2.00684272 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.97584349 |
| 26 | MP0001970_abnormal_pain_threshold | 1.94751633 |
| 27 | MP0002909_abnormal_adrenal_gland | 1.88840899 |
| 28 | MP0008569_lethality_at_weaning | 1.82140045 |
| 29 | MP0006276_abnormal_autonomic_nervous | 1.80944112 |
| 30 | MP0004858_abnormal_nervous_system | 1.80147620 |
| 31 | MP0002184_abnormal_innervation | 1.74545117 |
| 32 | MP0004924_abnormal_behavior | 1.71553565 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.71553565 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.68929534 |
| 35 | MP0003879_abnormal_hair_cell | 1.63014504 |
| 36 | MP0000778_abnormal_nervous_system | 1.61367580 |
| 37 | MP0004811_abnormal_neuron_physiology | 1.58827185 |
| 38 | MP0002837_dystrophic_cardiac_calcinosis | 1.53787738 |
| 39 | MP0004885_abnormal_endolymph | 1.53337737 |
| 40 | MP0001984_abnormal_olfaction | 1.50572874 |
| 41 | MP0004043_abnormal_pH_regulation | 1.42446524 |
| 42 | MP0000955_abnormal_spinal_cord | 1.41711029 |
| 43 | MP0002066_abnormal_motor_capabilities/c | 1.39996139 |
| 44 | MP0004147_increased_porphyrin_level | 1.35237319 |
| 45 | MP0003633_abnormal_nervous_system | 1.29022650 |
| 46 | MP0002882_abnormal_neuron_morphology | 1.28745392 |
| 47 | MP0010234_abnormal_vibrissa_follicle | 1.25946189 |
| 48 | MP0005646_abnormal_pituitary_gland | 1.25545440 |
| 49 | MP0001529_abnormal_vocalization | 1.23157584 |
| 50 | MP0004084_abnormal_cardiac_muscle | 1.19558919 |
| 51 | MP0004142_abnormal_muscle_tone | 1.19496655 |
| 52 | MP0001905_abnormal_dopamine_level | 1.18886622 |
| 53 | MP0000751_myopathy | 1.17717203 |
| 54 | MP0008872_abnormal_physiological_respon | 1.16331658 |
| 55 | MP0001502_abnormal_circadian_rhythm | 1.15745163 |
| 56 | MP0003787_abnormal_imprinting | 1.15301990 |
| 57 | MP0005645_abnormal_hypothalamus_physiol | 1.14955921 |
| 58 | MP0002139_abnormal_hepatobiliary_system | 1.14374521 |
| 59 | MP0003631_nervous_system_phenotype | 1.09161921 |
| 60 | MP0004145_abnormal_muscle_electrophysio | 1.08356991 |
| 61 | MP0000604_amyloidosis | 1.06334692 |
| 62 | MP0003122_maternal_imprinting | 1.03901804 |
| 63 | MP0010386_abnormal_urinary_bladder | 1.03341692 |
| 64 | MP0003283_abnormal_digestive_organ | 1.02487767 |
| 65 | MP0008875_abnormal_xenobiotic_pharmacok | 1.02285750 |
| 66 | MP0004036_abnormal_muscle_relaxation | 1.01455330 |
| 67 | MP0005535_abnormal_body_temperature | 1.01451434 |
| 68 | MP0000013_abnormal_adipose_tissue | 1.01349939 |
| 69 | MP0005409_darkened_coat_color | 1.00667987 |
| 70 | MP0002152_abnormal_brain_morphology | 0.98359153 |
| 71 | MP0002638_abnormal_pupillary_reflex | 0.95959325 |
| 72 | MP0002069_abnormal_eating/drinking_beha | 0.95870012 |
| 73 | MP0008961_abnormal_basal_metabolism | 0.95547367 |
| 74 | MP0001756_abnormal_urination | 0.93920491 |
| 75 | MP0001348_abnormal_lacrimal_gland | 0.93716520 |
| 76 | MP0001765_abnormal_ion_homeostasis | 0.93408359 |
| 77 | MP0002229_neurodegeneration | 0.93267665 |
| 78 | MP0001188_hyperpigmentation | 0.92999795 |
| 79 | MP0002876_abnormal_thyroid_physiology | 0.92477095 |
| 80 | MP0003123_paternal_imprinting | 0.87229715 |
| 81 | MP0001177_atelectasis | 0.86055642 |
| 82 | MP0004085_abnormal_heartbeat | 0.85254027 |
| 83 | MP0001664_abnormal_digestion | 0.83231296 |
| 84 | MP0004742_abnormal_vestibular_system | 0.82399863 |
| 85 | * MP0008874_decreased_physiological_sensi | 0.81739747 |
| 86 | MP0001963_abnormal_hearing_physiology | 0.81481106 |
| 87 | MP0003075_altered_response_to | 0.79384135 |
| 88 | MP0003632_abnormal_nervous_system | 0.77657522 |
| 89 | MP0000566_synostosis | 0.77266034 |
| 90 | MP0003183_abnormal_peptide_metabolism | 0.73708517 |
| 91 | MP0005551_abnormal_eye_electrophysiolog | 0.72372144 |
| 92 | * MP0004484_altered_response_of | 0.72256675 |
| 93 | * MP0004215_abnormal_myocardial_fiber | 0.71904256 |
| 94 | MP0004233_abnormal_muscle_weight | 0.71093435 |
| 95 | MP0005394_taste/olfaction_phenotype | 0.70383215 |
| 96 | MP0005499_abnormal_olfactory_system | 0.70383215 |
| 97 | MP0004019_abnormal_vitamin_homeostasis | 0.70319316 |
| 98 | MP0010678_abnormal_skin_adnexa | 0.70215098 |
| 99 | MP0005166_decreased_susceptibility_to | 0.69939421 |
| 100 | MP0003634_abnormal_glial_cell | 0.69754276 |
| 101 | MP0008775_abnormal_heart_ventricle | 0.69039031 |
| 102 | MP0001485_abnormal_pinna_reflex | 0.68693632 |
| 103 | MP0005636_abnormal_mineral_homeostasis | 0.66926472 |
| 104 | MP0003137_abnormal_impulse_conducting | 0.64789376 |
| 105 | MP0005167_abnormal_blood-brain_barrier | 0.64781969 |
| 106 | MP0003690_abnormal_glial_cell | 0.64327444 |
| 107 | MP0002752_abnormal_somatic_nervous | 0.62523741 |
| 108 | MP0005332_abnormal_amino_acid | 0.62090218 |
| 109 | MP0004510_myositis | 0.60872378 |
| 110 | MP0003646_muscle_fatigue | 0.60510762 |
| 111 | MP0001346_abnormal_lacrimal_gland | 0.60387040 |
| 112 | MP0000920_abnormal_myelination | 0.59927040 |
| 113 | MP0000747_muscle_weakness | 0.58231759 |
| 114 | MP0005187_abnormal_penis_morphology | 0.56502785 |
| 115 | MP0000631_abnormal_neuroendocrine_gland | 0.55115838 |
| 116 | MP0002090_abnormal_vision | 0.53950171 |
| 117 | MP0001943_abnormal_respiration | 0.52832480 |
| 118 | MP0002234_abnormal_pharynx_morphology | 0.51740862 |
| 119 | MP0003956_abnormal_body_size | 0.49678358 |
| 120 | MP0005623_abnormal_meninges_morphology | 0.48876339 |
| 121 | MP0010769_abnormal_survival | 0.48639461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.99865897 |
| 2 | Myokymia (HP:0002411) | 6.37653585 |
| 3 | Focal seizures (HP:0007359) | 5.76315564 |
| 4 | Visual hallucinations (HP:0002367) | 5.55482679 |
| 5 | Atonic seizures (HP:0010819) | 5.00783669 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.66479544 |
| 7 | Febrile seizures (HP:0002373) | 4.57063681 |
| 8 | Absence seizures (HP:0002121) | 4.50220765 |
| 9 | Hyperphosphatemia (HP:0002905) | 4.22816603 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 4.21958927 |
| 11 | Dialeptic seizures (HP:0011146) | 4.02461556 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.97581062 |
| 13 | Tetany (HP:0001281) | 3.94950162 |
| 14 | Action tremor (HP:0002345) | 3.80064344 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 3.64076271 |
| 16 | Hyperventilation (HP:0002883) | 3.57578788 |
| 17 | Broad-based gait (HP:0002136) | 3.39008795 |
| 18 | Poor eye contact (HP:0000817) | 3.21836911 |
| 19 | Cerebral inclusion bodies (HP:0100314) | 3.13696544 |
| 20 | Abnormal social behavior (HP:0012433) | 3.10573919 |
| 21 | Impaired social interactions (HP:0000735) | 3.10573919 |
| 22 | Anxiety (HP:0000739) | 3.10034859 |
| 23 | Gaze-evoked nystagmus (HP:0000640) | 3.09394014 |
| 24 | Dysdiadochokinesis (HP:0002075) | 3.07095112 |
| 25 | Depression (HP:0000716) | 3.06527343 |
| 26 | Dysmetria (HP:0001310) | 3.02845727 |
| 27 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.00747649 |
| 28 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.00203988 |
| 29 | Abnormal eating behavior (HP:0100738) | 2.99694144 |
| 30 | Amblyopia (HP:0000646) | 2.98950610 |
| 31 | Truncal ataxia (HP:0002078) | 2.97544763 |
| 32 | Neurofibrillary tangles (HP:0002185) | 2.91583470 |
| 33 | Increased circulating renin level (HP:0000848) | 2.91331990 |
| 34 | Mutism (HP:0002300) | 2.82803609 |
| 35 | Ankle clonus (HP:0011448) | 2.81064766 |
| 36 | Postural instability (HP:0002172) | 2.78475356 |
| 37 | Ventricular fibrillation (HP:0001663) | 2.68894949 |
| 38 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.67688985 |
| 39 | Progressive inability to walk (HP:0002505) | 2.66173899 |
| 40 | Drooling (HP:0002307) | 2.65292545 |
| 41 | Excessive salivation (HP:0003781) | 2.65292545 |
| 42 | Papilledema (HP:0001085) | 2.62249094 |
| 43 | Diplopia (HP:0000651) | 2.60356018 |
| 44 | Abnormality of binocular vision (HP:0011514) | 2.60356018 |
| 45 | Scanning speech (HP:0002168) | 2.58419719 |
| 46 | Status epilepticus (HP:0002133) | 2.56797540 |
| 47 | Pheochromocytoma (HP:0002666) | 2.55400954 |
| 48 | Urinary urgency (HP:0000012) | 2.53157308 |
| 49 | Impaired smooth pursuit (HP:0007772) | 2.52274438 |
| 50 | Alacrima (HP:0000522) | 2.52089145 |
| 51 | Metabolic alkalosis (HP:0200114) | 2.51315711 |
| 52 | Genetic anticipation (HP:0003743) | 2.50376129 |
| 53 | Hemiparesis (HP:0001269) | 2.48448507 |
| 54 | Abnormality of the lower motor neuron (HP:0002366) | 2.47629860 |
| 55 | Obstructive sleep apnea (HP:0002870) | 2.45673246 |
| 56 | Bradykinesia (HP:0002067) | 2.45653117 |
| 57 | Hypomagnesemia (HP:0002917) | 2.44924661 |
| 58 | Epileptiform EEG discharges (HP:0011182) | 2.43239247 |
| 59 | Postural tremor (HP:0002174) | 2.41749804 |
| 60 | Hyperactive renin-angiotensin system (HP:0000841) | 2.41178341 |
| 61 | Intention tremor (HP:0002080) | 2.40648929 |
| 62 | Hemiplegia (HP:0002301) | 2.39853235 |
| 63 | Akinesia (HP:0002304) | 2.36775484 |
| 64 | Abnormality of magnesium homeostasis (HP:0004921) | 2.32945287 |
| 65 | Termporal pattern (HP:0011008) | 2.32588488 |
| 66 | Insidious onset (HP:0003587) | 2.32588488 |
| 67 | EEG with generalized epileptiform discharges (HP:0011198) | 2.27791565 |
| 68 | Inability to walk (HP:0002540) | 2.26550782 |
| 69 | Fetal akinesia sequence (HP:0001989) | 2.26469799 |
| 70 | Dysmetric saccades (HP:0000641) | 2.26299180 |
| 71 | Absent speech (HP:0001344) | 2.25595655 |
| 72 | Abnormality of chloride homeostasis (HP:0011422) | 2.22572754 |
| 73 | Stereotypic behavior (HP:0000733) | 2.20558403 |
| 74 | Spastic gait (HP:0002064) | 2.20364617 |
| 75 | Torticollis (HP:0000473) | 2.20265001 |
| 76 | Neuroendocrine neoplasm (HP:0100634) | 2.19177237 |
| 77 | Sudden death (HP:0001699) | 2.17508309 |
| 78 | Focal dystonia (HP:0004373) | 2.16685880 |
| 79 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.16272304 |
| 80 | Limb dystonia (HP:0002451) | 2.13766346 |
| 81 | Hypsarrhythmia (HP:0002521) | 2.13003726 |
| 82 | Polyphagia (HP:0002591) | 2.11859157 |
| 83 | Generalized myoclonic seizures (HP:0002123) | 2.08246690 |
| 84 | Abnormality of the corticospinal tract (HP:0002492) | 2.07339286 |
| 85 | Psychosis (HP:0000709) | 2.06260504 |
| 86 | Agitation (HP:0000713) | 2.05064590 |
| 87 | Abnormality of saccadic eye movements (HP:0000570) | 2.02707751 |
| 88 | Abnormality of vitamin metabolism (HP:0100508) | 2.00701636 |
| 89 | Megalencephaly (HP:0001355) | 1.98557277 |
| 90 | Hypokalemic alkalosis (HP:0001949) | 1.98265332 |
| 91 | Sleep apnea (HP:0010535) | 1.98177394 |
| 92 | Rapidly progressive (HP:0003678) | 1.98156960 |
| 93 | Amyotrophic lateral sclerosis (HP:0007354) | 1.96992667 |
| 94 | Syncope (HP:0001279) | 1.96945093 |
| 95 | Hypokalemia (HP:0002900) | 1.95550773 |
| 96 | Impaired vibratory sensation (HP:0002495) | 1.95321555 |
| 97 | Lower limb asymmetry (HP:0100559) | 1.92687071 |
| 98 | Hyperaldosteronism (HP:0000859) | 1.92322389 |
| 99 | Heart block (HP:0012722) | 1.91151453 |
| 100 | Gait ataxia (HP:0002066) | 1.91146881 |
| 101 | Bundle branch block (HP:0011710) | 1.90830155 |
| 102 | Lower limb muscle weakness (HP:0007340) | 1.90189233 |
| 103 | Craniofacial dystonia (HP:0012179) | 1.89871331 |
| 104 | Decreased lacrimation (HP:0000633) | 1.89641398 |
| 105 | Abnormality of vitamin B metabolism (HP:0004340) | 1.89331159 |
| 106 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.88450622 |
| 107 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.88450622 |
| 108 | Delusions (HP:0000746) | 1.88323995 |
| 109 | Abnormality of renin-angiotensin system (HP:0000847) | 1.88214724 |
| 110 | Neuronal loss in central nervous system (HP:0002529) | 1.86397744 |
| 111 | Annular pancreas (HP:0001734) | 1.86108434 |
| 112 | Abnormality of potassium homeostasis (HP:0011042) | 1.85087099 |
| 113 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.84663843 |
| 114 | Gout (HP:0001997) | 1.84588652 |
| 115 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.81966749 |
| 116 | Renal salt wasting (HP:0000127) | 1.81354870 |
| 117 | Incomplete penetrance (HP:0003829) | 1.78296783 |
| 118 | Rigidity (HP:0002063) | 1.77571391 |
| 119 | Abnormal atrioventricular conduction (HP:0005150) | 1.77050153 |
| 120 | Abnormality of salivation (HP:0100755) | 1.76985827 |
| 121 | Abnormal EKG (HP:0003115) | 1.76170646 |
| 122 | Hyperparathyroidism (HP:0000843) | 1.75238621 |
| 123 | Resting tremor (HP:0002322) | 1.71058964 |
| 124 | Adrenal overactivity (HP:0002717) | 1.70837053 |
| 125 | Decreased circulating renin level (HP:0003351) | 1.70392435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.66749929 |
| 2 | EPHA4 | 4.32675687 |
| 3 | MAP3K9 | 3.90256705 |
| 4 | MAP3K4 | 3.09791238 |
| 5 | MINK1 | 2.73160232 |
| 6 | RIPK4 | 2.51264143 |
| 7 | MAP2K7 | 2.51038033 |
| 8 | MARK1 | 2.44013142 |
| 9 | MAP3K12 | 2.34881230 |
| 10 | KSR2 | 2.34687615 |
| 11 | DAPK2 | 2.10714126 |
| 12 | MAP2K4 | 2.10109674 |
| 13 | PAK6 | 1.98212759 |
| 14 | NTRK1 | 1.97181987 |
| 15 | PNCK | 1.91789779 |
| 16 | NTRK2 | 1.66299604 |
| 17 | KSR1 | 1.63857357 |
| 18 | CAMKK1 | 1.62853228 |
| 19 | ARAF | 1.60268553 |
| 20 | PLK2 | 1.51972386 |
| 21 | PRKD3 | 1.49977164 |
| 22 | GRK5 | 1.48964019 |
| 23 | DAPK1 | 1.48492808 |
| 24 | STK38 | 1.46049323 |
| 25 | OXSR1 | 1.45559843 |
| 26 | CDK5 | 1.43975184 |
| 27 | MAP3K2 | 1.37369933 |
| 28 | MAP3K13 | 1.26425010 |
| 29 | EPHA2 | 1.25698563 |
| 30 | PRKCG | 1.24267419 |
| 31 | LMTK2 | 1.24173439 |
| 32 | CASK | 1.23161093 |
| 33 | SIK2 | 1.21476064 |
| 34 | WNK4 | 1.21019970 |
| 35 | WNK3 | 1.17863227 |
| 36 | CAMKK2 | 1.09428625 |
| 37 | FES | 1.08182256 |
| 38 | CDK19 | 1.07951682 |
| 39 | CAMK2A | 1.07234775 |
| 40 | LATS2 | 1.04953986 |
| 41 | OBSCN | 1.01952393 |
| 42 | MST1R | 0.99914187 |
| 43 | TNIK | 0.98499465 |
| 44 | CAMK2B | 0.97106038 |
| 45 | PHKG1 | 0.97000413 |
| 46 | PHKG2 | 0.97000413 |
| 47 | NME1 | 0.96764308 |
| 48 | BMPR2 | 0.94954946 |
| 49 | PTK2B | 0.93665585 |
| 50 | MAPK13 | 0.91968969 |
| 51 | TYRO3 | 0.91531615 |
| 52 | LIMK1 | 0.91166744 |
| 53 | PAK3 | 0.91086366 |
| 54 | RAF1 | 0.90195124 |
| 55 | MAPK12 | 0.87774624 |
| 56 | PIK3CA | 0.85314369 |
| 57 | NEK6 | 0.84516751 |
| 58 | UHMK1 | 0.84178489 |
| 59 | RET | 0.84147830 |
| 60 | SGK494 | 0.83499832 |
| 61 | SGK223 | 0.83499832 |
| 62 | CAMK1 | 0.83332573 |
| 63 | TESK1 | 0.82151418 |
| 64 | WNK1 | 0.78776062 |
| 65 | PINK1 | 0.78296361 |
| 66 | STK11 | 0.78109913 |
| 67 | CDK18 | 0.77322423 |
| 68 | CDK14 | 0.76605235 |
| 69 | CDK15 | 0.76177227 |
| 70 | FER | 0.76081353 |
| 71 | PDK2 | 0.75539877 |
| 72 | TAOK1 | 0.75145681 |
| 73 | PRKG2 | 0.74781254 |
| 74 | SGK1 | 0.70832089 |
| 75 | STK39 | 0.70806511 |
| 76 | PRPF4B | 0.70348079 |
| 77 | PRKCH | 0.69091182 |
| 78 | SGK2 | 0.68449011 |
| 79 | MAP3K1 | 0.67978957 |
| 80 | CAMK2D | 0.64968255 |
| 81 | CDK11A | 0.64718282 |
| 82 | CSNK1G2 | 0.64557237 |
| 83 | PDPK1 | 0.63249202 |
| 84 | PDK1 | 0.62926176 |
| 85 | SGK3 | 0.61005233 |
| 86 | DYRK1A | 0.60898327 |
| 87 | CAMK2G | 0.60443370 |
| 88 | FGFR2 | 0.57263215 |
| 89 | NEK1 | 0.57223829 |
| 90 | MAP2K1 | 0.56702740 |
| 91 | MET | 0.56610471 |
| 92 | CAMK1G | 0.56598712 |
| 93 | CAMK4 | 0.56311593 |
| 94 | FGR | 0.54718660 |
| 95 | MAP3K7 | 0.54417526 |
| 96 | PRKCE | 0.54139441 |
| 97 | SCYL2 | 0.53595669 |
| 98 | PRKCZ | 0.49835040 |
| 99 | PDK3 | 0.49754654 |
| 100 | PDK4 | 0.49754654 |
| 101 | DMPK | 0.49077277 |
| 102 | MAP3K6 | 0.48754381 |
| 103 | RIPK1 | 0.48049621 |
| 104 | ALK | 0.47789604 |
| 105 | PRKCA | 0.46977106 |
| 106 | TNK2 | 0.46442981 |
| 107 | MAPKAPK5 | 0.46433004 |
| 108 | MARK2 | 0.45573290 |
| 109 | MAP3K3 | 0.44887951 |
| 110 | MAPKAPK3 | 0.42730596 |
| 111 | CDC42BPA | 0.42595123 |
| 112 | BCR | 0.42398130 |
| 113 | PRKG1 | 0.42145819 |
| 114 | ERBB2 | 0.41878151 |
| 115 | RPS6KA3 | 0.41737154 |
| 116 | BRAF | 0.41341428 |
| 117 | FYN | 0.40262493 |
| 118 | MAP2K6 | 0.39633224 |
| 119 | ROCK2 | 0.39589046 |
| 120 | GRK6 | 0.39393541 |
| 121 | CSNK1A1 | 0.38505606 |
| 122 | MAPK10 | 0.36552706 |
| 123 | FRK | 0.36050994 |
| 124 | AKT3 | 0.32525246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.80841200 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.21769025 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.80649277 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.64893180 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.60255368 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.58149558 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.50755361 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.48864370 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.47414688 |
| 10 | * Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.36303349 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.31012171 |
| 12 | * Salivary secretion_Homo sapiens_hsa04970 | 2.15837347 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.11522644 |
| 14 | * Gastric acid secretion_Homo sapiens_hsa04971 | 1.95796308 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.92021583 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.85634842 |
| 17 | * Insulin secretion_Homo sapiens_hsa04911 | 1.84964773 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.74082201 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.73653494 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.73487636 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.72830599 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.61769960 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.58564187 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.56718358 |
| 25 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.56643194 |
| 26 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.55840386 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.49567527 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.42570186 |
| 29 | * Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.40824300 |
| 30 | * Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.28268270 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.27411687 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.23416369 |
| 33 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.19377993 |
| 34 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.17374668 |
| 35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.14629238 |
| 36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.13903214 |
| 37 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.13522897 |
| 38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.12824964 |
| 39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.07063489 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.06285199 |
| 41 | Glioma_Homo sapiens_hsa05214 | 1.02189809 |
| 42 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.98755503 |
| 43 | Melanogenesis_Homo sapiens_hsa04916 | 0.97995812 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 0.97191932 |
| 45 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.97027872 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.95393542 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.91754122 |
| 48 | * Pancreatic secretion_Homo sapiens_hsa04972 | 0.91399565 |
| 49 | Axon guidance_Homo sapiens_hsa04360 | 0.91134891 |
| 50 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.89514508 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88424920 |
| 52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87471463 |
| 53 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.85868564 |
| 54 | Alzheimers disease_Homo sapiens_hsa05010 | 0.81790390 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81628700 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81373166 |
| 57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.80138979 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76731774 |
| 59 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.76563327 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75171306 |
| 61 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.74096020 |
| 62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71881429 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70631173 |
| 64 | * Bile secretion_Homo sapiens_hsa04976 | 0.69848112 |
| 65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.69016119 |
| 66 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67391002 |
| 67 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66153526 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64326012 |
| 69 | Tight junction_Homo sapiens_hsa04530 | 0.61095364 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.60628593 |
| 71 | Phototransduction_Homo sapiens_hsa04744 | 0.58899061 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56574909 |
| 73 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.56168912 |
| 74 | * Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54981451 |
| 75 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53771990 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53388922 |
| 77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53313737 |
| 78 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.52526661 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52453627 |
| 80 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.51826800 |
| 81 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 0.51658218 |
| 82 | Parkinsons disease_Homo sapiens_hsa05012 | 0.51020341 |
| 83 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.48976553 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47874461 |
| 85 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45846147 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45122233 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43836589 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43298786 |
| 89 | * Mineral absorption_Homo sapiens_hsa04978 | 0.41161243 |
| 90 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.40790531 |
| 91 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.40740342 |
| 92 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.39975548 |
| 93 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.39275497 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38602634 |
| 95 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38475818 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38471609 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38366605 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37964374 |
| 99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36691192 |
| 100 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.36544507 |
| 101 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36027664 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35844630 |
| 103 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35840994 |
| 104 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.35111404 |
| 105 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35051055 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.33653998 |
| 107 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33451952 |
| 108 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.32383347 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.32343557 |
| 110 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.32248777 |
| 111 | Alcoholism_Homo sapiens_hsa05034 | 0.31823401 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.31537262 |
| 113 | Circadian rhythm_Homo sapiens_hsa04710 | 0.30826036 |
| 114 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30100059 |
| 115 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30043626 |
| 116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29734917 |
| 117 | Huntingtons disease_Homo sapiens_hsa05016 | 0.29321437 |
| 118 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28505489 |
| 119 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.27890581 |
| 120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27364974 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26333564 |

